HTEC Among Disruptive Tech ETFs
End-of-day Nov 18, 2026 · 25 Disruptive tech ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | −5.6% | −3.3% | +0.1% | +20.6% | +30.1% | +85.8% | −6.3% | — | +77.6% |
| Peer average | +0.4% | −5.3% | −6.7% | −7.4% | +3.2% | +5.8% | +67.8% | +9.3% | +319.0% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$23 of every $1,000 in HTEC is Intuitive
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ISRGIntuitive Surgical | Healthcare | 2.32% | $232.08 | 5,138 | $2.2M |
| 2 | GKOSGlaukos | Healthcare | 2.31% | $230.79 | 9,043 | $2.2M |
| 3 | AXGNAxogen | Healthcare | 2.28% | $227.58 | 39K | $2.2M |
| 4 | TMOThermo Fisher Scientific | Healthcare | 2.21% | $221.14 | 3,069 | $2.1M |
| 5 | CDNACaredx | Healthcare | 2.21% | $220.95 | 28K | $2.1M |
| 6 | GRALGrail | Healthcare | 2.20% | $219.65 | 20K | $2.1M |
| 7 | MRNAModerna | Healthcare | 2.11% | $211.24 | 9,736 | $2.0M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 2.10% | $209.92 | 2,089 | $2.0M |
| 9 | LIVNLivanova | Healthcare | 2.09% | $209.15 | 22K | $2.0M |
| 10 | SYKStryker | Healthcare | 2.08% | $207.82 | 6,238 | $2.0M |
| 11 | PHIA.ASKoninklijke Philips | Healthcare | 2.07% | $206.70 | 66K | $2.0M |
| 12 | ADPTAdaptive Biotechnologies | Healthcare | 2.05% | $204.91 | 69K | $2.0M |
| 13 | SHL.DESiemens Healthineers AG | Healthcare | 2.04% | $204.48 | 41K | $1.9M |
| 14 | MEDPMedpace | Healthcare | 2.03% | $203.23 | 2,966 | $1.9M |
| 15 | LONN.SWLonza Group AG | Healthcare | 2.03% | $202.62 | 2,444 | $1.9M |
of the $46.3B in 27 Disruptive tech ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ISRG | Intuitive Surgical | 2.32% |
| 2 | GKOS | Glaukos | 2.31% |
| 3 | AXGN | Axogen | 2.28% |
| 4 | TMO | Thermo Fisher Scientific | 2.21% |
| 5 | CDNA | Caredx | 2.21% |
| 6 | GRAL | Grail | 2.20% |
| 7 | MRNA | Moderna | 2.11% |
| 8 | REGN | Regeneron Pharmaceuticals | 2.10% |
| 9 | LIVN | Livanova | 2.09% |
| 10 | SYK | Stryker | 2.08% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.35 |
| Dec 28, 2021 | Dec 31, 2021 | $0.0230 |